Pharmacy Technician Pulse

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

tag scotland

NICE reaches a deal with Roche on access to oral SMA drug Evrysdi

pharmaphorum

NOVEMBER 19, 2021

million price tag make it is the most expensive treatment ever approved for NHS funding. Meanwhile, in Scotland, the drug is currently under evaluation by the Scottish Medicines Consortium (SMC) with a verdict expected in early 2022. The post NICE reaches a deal with Roche on access to oral SMA drug Evrysdi appeared first on.

Drug-resistant epilepsy drug Ontozry backed by NICE

pharmaphorum

NOVEMBER 16, 2021

“We look forward to the full technology appraisal guidance (TAG) which is due to be published in early December 2021,” he added. An opinion from the Scottish Medicine Consortium (SMC) on the use of the drug by NHS Scotland is expected to be published early in 2022.

Documentation

NICE reaches a deal with Roche on access to oral SMA drug Evrysdi

Drug-resistant epilepsy drug Ontozry backed by NICE

Stay Connected